Discontinuation of primary prophylaxis against Mycobacterium avium complex infection in HIV-infected persons receiving antiretroviral therapy:: Observations from a large national cohort in the United States, 1992-2002

被引：8

作者：

Brooks, JT

Song, RG

Hanson, DL

Wolfe, M

Swerdlow, DL

机构：

[1] Ctr Dis Control & Prevent, DHAP, NCHSTP, Clin Epidemiol Sect,Epidemiol Branch, Atlanta, GA 30333 USA

[2] Ctr Dis Control & Prevent, Stat & Data Management Branch, Atlanta, GA 30333 USA

[3] Ctr Dis Control & Prevent, Natl Ctr HIV STD & TB Prevent, Div HIV AIDS Prevent, Behav & Clin Surveillance Branch,Clin Outcomes Se, Atlanta, GA 30333 USA

来源：

CLINICAL INFECTIOUS DISEASES | 2005年 / 41卷 / 04期

关键词：

D O I：

10.1086/432057

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

In a large, diverse cohort of human immunodeficiency virus (HIV)-infected persons receiving routine care, the proportion of eligible persons who discontinued primary prophylaxis against Mycobacterium avium complex ( MAC) infection, according to guidelines of the US Public Health Service and the Infectious Diseases Society of America, increased from 16.7% (in 1996) to 84.9% ( in 2002). The discontinuation of primary prophylaxis was not associated with an increased risk of disseminated MAC infection.

引用

页码：549 / 553

页数：5

共 8 条

[1] Discontinuation of Mycobacterium avium complex prophylaxis in patients with antiretroviral therapy-induced increases in CD4+ cell count -: A randomized, double-blind, placebo-controlled trial [J].